LegalCaseDocs.com
shopping cart  
  |     
Search
 

 
New Visitors


 VeriSign Secure Site

 Get Adobe Reader

CHIN v DRKOOP.COM INC Click to find out why . . .



Keywords & Phrases
CaseNo: CVDCI102086, Plaintiff: CHIN, State: NY New York, UniqueCaseRef: LCD>CVDCI102086, Drkoop, Securities, Act, Commissions, Underwriter Defendants, Exchange, Price, Stock, York, Offering, Reports, Shares, Ipo, Material Facts, Misleading, Common Stock, Prospectus, Class Period, Manipulation, Violations, Investment Banks, Regulation, After-market, Participation, Materially False, United States, Wall Street , ContentID: 120248150

Case Documents
1 1999-06-08 COMPLAINT
[ see first page and extracted highlights below  ] ItemID: 119976
39 pages
PDF
Total Documents: 1 document , 39 pages
Price: $ 19.95


IVESLCD01 KGI0001
 
 

 Forgot your password?


1 . COMPLAINT

EXTRACTED KEY WORDS
SECURITIES
PLAINTIFF
ACT
DEFENDANTS
COMMISSIONS
UNDERWRITER DEFENDANTS
EXCHANGE
PRICE
STOCK
YORK
OFFERING
REPORTS
SHARES
IPO
MEMBERS
MATERIAL FACTS
MISLEADING
COMMON STOCK
PROSPECTUS
CLASS PERIOD
MANIPULATION
VIOLATIONS
INVESTMENT BANKS
REGULATION
AFTER-MARKET
PARTICIPATION
MATERIALLY FALSE
UNITED STATES
WALL STREET
UNITED STATES DISTRICT COURT
SOUTHERN DISTRICT OF NEW YORK

     JIMMY CHIN, on behalf of himself and all others
     similarly situated,
                                                                    CIVIL ACTION NO.
                              Plaintiff,
                                                                    CLASS ACTION COMPLAINT
                                v.                                  FOR VIOLATIONS OF FEDERAL
                                                                    SECURITIES LAWS
     DRKOOP.COM, INC.; DONALD HACKETT;
     C. EVERETT KOOP; SUSAN                                         JURY TRIAL DEMANDED
     GEORGEN-SAAD; LOUIS SCALPATI; BANC
     OF AMERICA SECURITIES LLC; BEAR
     STEARNS, & CO., INC.; B.T. ALEX. BROWN,
     INC.; FLEETBOSTON ROBERTSON
     STEPHENS, INC.; GOLDMAN, SACHS & CO.;
      J.P. MORGAN CHASE; and MERRILL LYNCH,
     PIERCE, FENNER & SMITH,
     INCORPORATED,

                              Defendants.

            Plaintiff, individually and on behalf of all other persons similarly situated, by

attorneys, for plaintiff's Complaint, allege upon the investigation made by and through plaintiff's

which included,  inter  alia, a review of relevant filings made by drKoop.com, Inc. ("DrKoop" or the

"Company") with the Securities and Exchange Commission, as well as, tele-conferences, press

news articles, analyst reports, and media reports concerning the Company.  Furthermore, this

is based upon plaintiff's personal knowledge as to plaintiff  and plaintiff's own acts, and upon

and belief as to all other matters, based upon the aforementioned investigation.

                                             NATURE OF THE ACTION

            1.       This is a class action on behalf of all persons, other than defendants and

parties, who purchased, converted, exchanged or otherwise acquired DrKoop common stock, as defined



below, including, but not limited to, during the period from June 8, 1999 through December 6, 2000

"Class Period")  to recover damages caused by defendants' violations of the federal securities law.

SNIPPETS:
  • UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK
  • Plaintiff, individually and on behalf of all other persons similarly situated, by plaintiff's
  • which included, inter alia, a review of relevant filings made by drKoop.com, Inc. ("DrKoop"
  • "Company") with the Securities and Exchange Commission, as well as, tele-conferences, press
  • news articles, analyst reports, and media reports concerning the Company.
  • "Class Period") to recover damages caused by defendants' violations of the federal securities
  • alleged malfeasance by major Wall Street securities firms.
  • investment banks charged issuers of new securities excessive commissions and inflated
  • Second, investigators are examining, and have evidence, that major investment banks
  • exchange for promises by these customers that they would purchase additional shares of the
  • after-market, thereby inflating and maintaining the market price for the IPOs.
  • participation in the IPO market and after-market trading.
  • inflation in the IPO stock price, above the offering price, and create a false sense of
  • obtain allocations of stock on the offering - - but before the first after-market trade.
  • Securities Act of 1933 15 U.S.C. '' 77k, 77land 77o and Sections 10and
  • including the preparation and dissemination in this judicial district of the Prospectus
  • shareholders of defendants DrKoop, which documents were materially false and misleading,
  • Class Period (including the trading of DrKoop stock based upon misleading information).
  • underwriter defendants conduct substantial business in this district.
  • managing underwriter of the DrKoop initial public offering of 9,375,000 shares of common
  • The members of the Class are so numerous that joinder of all members is
  • Manipulated Securities omitted and/or misrepresented material facts about the offering of
  • In direct contravention to Rules 101 and 102 of Regulation M of the Exchange Act,
  • direct participation and agreement of DrKoop and the Individual Defendants.
  • violation of Regulation M, which governs market manipulation.
  •    |